REPORTS
Blue Pill or Red Pill: The Limits of Comparative Effectiveness Research
by Tomas J. Philipson, Eric Sun, June 2011
How Conflict-of-Interest Rules Endanger Medical Progress and Cures
by Richard A. Epstein, October 2010
Cost of Caution: The Impact on Patients of Delayed Drug Approvals
by Tomas J. Philipson, Eric Sun, June 2010
In the Wake of Wyeth v. Levine: Making the Case for FDA Preemption and Administrative Compensation
by James R. Copland, Paul Howard, March 2009
keep in touch     |
|
For more information or to speak with one of the experts, contact: |
